Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 981 entries
View as:

POASAC Study (Preoperative Anemia Severity and Classification Study)

Phase: N/A Priority: Normal
NCT ID: NCT06499974 Org: User:
Start: 08/02/24 End: 12/31/26 Due: 12/31/27

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Phase: N/A Priority: Normal
NCT ID: NCT04689893 Org: User:
Start: 03/15/20 End: 03/15/22 Due: 03/15/23

Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT05617872 Org: User:
Start: 12/30/22 End: 12/31/25 Due: 12/31/26

Online Adaptive Radiation Therapy for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05911789 Org: User:
Start: 08/05/23 End: 06/01/25 Due: 06/01/26

A Multicentered Prospective Cohort Study of Chinese IBD Patients

Phase: N/A Priority: Normal
NCT ID: NCT05386290 Org: User:
Start: 07/09/20 End: 12/31/23 Due: 12/31/24

Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01613079 Org: User:
Start: 05/31/12 End: 06/30/13 Due: 06/30/14

Hepatobiliary Tumors Tissue Samples Acquisition

Phase: N/A Priority: Normal
NCT ID: NCT04445532 Org: User:
Start: 10/11/20 End: 06/01/25 Due: 06/01/26

Wearable Electrocardiogram Monitoring Device and Smartphone Application in Perioperative Pain Management

Phase: N/A Priority: Normal
NCT ID: NCT04686526 Org: User:
Start: 07/01/23 End: 12/31/25 Due: 12/31/26

Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04164745 Org: User:
Start: 11/16/19 End: 11/16/22 Due: 11/16/23

Corticosteroid Therapy for Severe Community-Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT02552342 Org: User:
Start: 05/31/15 End: 05/31/17 Due: 05/31/18

Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT02784041 Org: User:
Start: 09/30/16 End: 12/31/18 Due: 12/31/19

A Study About Nutritional Support of Enhanced Protein in Critical Patients

Phase: N/A Priority: Normal
NCT ID: NCT04177446 Org: User:
Start: 12/25/19 End: 05/31/20 Due: 05/31/21

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Phase: N/A Priority: Normal
NCT ID: NCT02817945 Org: User:
Start: 06/01/16 End: 12/31/22 Due: 12/31/23

99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05622240 Org: User:
Start: 09/07/22 End: 12/31/23 Due: 12/31/24

The Investigation of Public Awareness of Core Stroke Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03167346 Org: User:
Start: 01/01/17 End: 06/30/21 Due: 06/30/22

Mordified Restoration of Tensor Veli Palatini in Cleft Palate Repair

Phase: N/A Priority: Normal
NCT ID: NCT04366674 Org: User:
Start: 01/01/13 End: 06/30/19 Due: 06/30/20

Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7

Phase: N/A Priority: Normal
NCT ID: NCT06020755 Org: User:
Start: 12/31/24 End: 08/31/25 Due: 08/31/26

Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02483767 Org: User:
Start: 06/30/15 End: 11/30/16 Due: 11/30/17

Melatonin in Patients Under Carotid Endarterectomy

Phase: N/A Priority: Normal
NCT ID: NCT03115034 Org: User:
Start: 06/01/16 End: 11/01/17 Due: 11/01/18

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Phase: N/A Priority: Normal
NCT ID: NCT03500367 Org: User:
Start: 01/01/18 End: 12/31/22 Due: 12/31/23

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Phase: N/A Priority: Normal
NCT ID: NCT06388031 Org: User:
Start: 08/09/24 End: 12/10/27 Due: 12/10/28

Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6

Phase: N/A Priority: Normal
NCT ID: NCT06028672 Org: User:
Start: 09/12/23 End: 08/31/25 Due: 08/31/26

68Ga-PMD22 PET/CT Examination Targeting CLDN18.2

Phase: N/A Priority: Normal
NCT ID: NCT05937919 Org: User:
Start: 05/28/23 End: 08/31/23 Due: 08/31/24

The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04261426 Org: User:
Start: 02/10/20 End: 06/30/20 Due: 06/30/21

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06056362 Org: User:
Start: 03/23/23 End: 03/27/25 Due: 03/27/26